{
    "patient": {
        "Name": "Jasmine Hood",
        "DateOfBirth": "1960-09-25",
        "Sex": "Male",
        "Diagnosis": "Squamous cell carcinoma",
        "BodyPart": "Prostate",
        "Physician": "Dr. Rachel Wright",
        "TreatingInstitution": "Crawford and Sons"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Prostate",
            "CollectedDate": "2023-11-30",
            "ReceivedDate": "2023-11-30",
            "TumorPercentage": "65%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-12-07",
            "ReceivedDate": "2023-12-09"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "BRCA1",
                "DNA Alteration": "c.5265_5266insC",
                "GeneMutation": "p.E23Vfs*17 Frameshift-LOF",
                "VariantAlleleFraction": "15.0%"
            },
            {
                "Gene": "TOP2A",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A1515S Frameshift-LOF",
                "VariantAlleleFraction": "7.18%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "ARID2",
                "DNA Alteration": " c.798G>A",
                "GeneMutation": "p.A1515S Stopgain-LOF",
                "VariantAlleleFraction": "10.79%"
            },
            {
                "Gene": "ALDH2",
                "DNA Alteration": "c.1510G>A",
                "GeneMutation": "p.A1515S Stopgain-LOF",
                "VariantAlleleFraction": "21.97%"
            },
            {
                "Gene": "DDR2",
                "DNA Alteration": "c.716T>G",
                "GeneMutation": "p.L239R Stopgain-LOF",
                "VariantAlleleFraction": "10.49%"
            },
            {
                "Gene": "ERCC2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.E504K Stopgain-LOF",
                "VariantAlleleFraction": "12.08%"
            },
            {
                "Gene": "PKLR",
                "DNA Alteration": "c.1436G>A",
                "GeneMutation": "p.F332V Spliceregionvariant-LOF",
                "VariantAlleleFraction": "1.33%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "MUTYH",
            "ALK",
            "DNMT3A",
            "PTEN"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "2 m/Mb",
            "Tmbpercentile": "31%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Equivocal"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}